Search studies using keywords
325 Studies contain the keyword metabolic (showing 121-140)
Pages: 1 2 3 4 5 6 7 8 9 10 >>
No data sets (in No Studies) added to Browser
Identifier Name Phenotype(s) Total p-values Related citationsAdd data sets to Browser Related data
HGVST2591 plus GWAS of Urinary 1,3-butadiene metabolite levels in smokers 
  • Urinary 1,3-butadiene metabolite levels in smokers
3
HGVST2547 plus GWAS of Macular telangiectasia type 2 
  • Macular telangiectasia type 2
5
HGVST2548 plus GWAS of Lipids 
  • HDL cholesterol
  • Triglycerides
  • Cholesterol, total
  • LDL cholesterol
243
HGVST2525 plus GWAS of Amyotrophic lateral sclerosis 
  • Amyotrophic lateral sclerosis (sporadic)
91
HGVST2533 plus GWAS of Interleukin levels 
  • Interleukin-10 levels
  • Interleukin-6 levels
  • Interleukin-1-receptor antagonist levels
23
HGVST2537 plus GWAS of Serum uric acid levels 
  • Serum uric acid levels
7
HGVST2538 plus GWAS of Type 2 diabetes 
  • Type 2 diabetes
10
HGVST2520 plus GWAS of Caffeine metabolism 
  • Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)
  • Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)
  • Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)
  • Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)
  • Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)
47
HGVST2496 plus GWAS of Ticagrelor levels 
  • AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor
  • Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor
8
HGVST2486 plus GWAS of Body mass index 
  • Body mass index
269
HGVST2488 plus GWAS of Magnesium levels 
  • Magnesium levels
5
HGVST2480 plus GWAS of Body fat distribution 
  • Pericardial adipose tissue adjusted for height and weight
  • Subcutaneous adipose tissue
  • Visceral adipose tissue adjusted for BMI
  • Visceral adipose tissue
  • Visceral adipose tissue attenuation (Hounslow unit scale)
  • Visceral adipose tissue/subcutaneous adipose tissue ratio
  • Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI
  • Subcutaneous adipose tissue attenuation (Hounsfield unit scale)
  • Pericardial fat
19
HGVST2463 plus GWAS of Pharmacokinetics of psychotropic drugs 
  • Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)
  • Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)
  • Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)
  • Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)
12
HGVST2470 plus GWAS of Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis 
  • Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
14
HGVST2415 plus GWAS of CSF tryptophan concentration in tuberculous meningitis 
  • CSF tryptophan concentration in tuberculous meningitis
10
HGVST2407 plus GWAS of Metabolic syndrome 
  • HDL cholesterol
  • Metabolic syndrome
  • Fasting blood glucose
  • Diastolic blood pressure
  • Waist circumference
  • Systolic blood pressure
  • Triglyceride levels
8
HGVST2410 plus GWAS of Cardiovascular and metabolic risk 
  • Hip circumference (psychosocial stress interaction)
5
HGVST2383 plus GWAS of Longevity 
  • Longevity
9
HGVST2384 plus GWAS of Hearing threshold shift 
  • Noise-induced hearing loss
1
HGVST2392 plus GWAS of Metabolic traits 
  • Urinary metabolites (H-NMR features)
21